Exelixis Inc at Barclays Global Healthcare Conference Transcript
Thank you so much. First and foremost, I'll probably be saying this for the rest of the day, but I just the fact that I was coming down to Miami, first in-person conference for 2 years, for Barclays, for Wall Street, et cetera. And my name is Peter Lawson, I'm going to be the moderator of this and was biotech analyst of Barclays doing (inaudible) oncology. And just wanted to thank Chris Senner, CFO; and Andrew Peters, SVP of Strategy, who also kind of made it across to Miami as well to do this in person.
And I guess the first question would be just, I guess, you're going to do an overview when we touch upon the differentiation.
Yes, just like to say, thanks for having us. It's been -- like you said, it's been 2 years, last in-person conference we did was Cowen 2020. So thank you for having us. And really appreciate the invitation. From a forward-looking perspective, during the course of the conversation, this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
